Nova Laboratories Ltd.

Latest from Nova Laboratories

Keeping you up to date with the very latest from Nova Laboratories. Click on the links below to view the news articles.

• 21/05/2013 Nova Laboratories will be participating at Phacilitate- Partnering For Vaccine Emerging Markets event held in Berlin 10-11 June 2013.
• 22/04/2013 Please note our offices will be open over the following days during the May bank Holiday.
• 22/04/2013 Nova will be exhibiting at this year’s Clinical Pharmacy Congress April 26th – 27th 2013 ExCel, London Please come and visit us on Stand D30
• 11/03/2013 Nova would like to wish all our customers a very Happy Easter, please click to see our opening hours:
• 25/02/2013 Nova’s innovative Hydris stabilisation device will be featured on the BBC’s Bang Goes The Theory programme on March 18th at 7:30 on BBC One.
• 11/02/2013 Sam de Costa, stabilization project manager at Nova Laboratories believes aseptic spray drying is a viable alternative to traditional lyophilisation techniques.
• 21/01/2013 NEWS BULLETIN - In response to customer requests, Nova are pleased to announce the addition of our full ‘Specials’ product portfolio. This can be found within the Product & Services > Specials Manufacturing section of this site.
• 09/01/2013 Nova Laboratories were recently visited by the BBC to cover Nova’s exciting stabilisation platform; HydRIS® (Hyperdermic Rehydration Injection System).
• 05/12/2012 Nova would like wish our customers a Merry Christmas and a Happy New Year! …. For Christmas opening times please click here:
• 30/11/2012 Nova Laboratories Ltd our proud to announce the launch of it's brand new Xaluprine site for both carers and healthcare professionals
• 30/11/2012 The European Commission has approved a revised formulation of Xaluprine (mercaptopurine oral suspension) which no longer contains the preservative propyl parabens.
• 26/10/2012 Despite testing times for the pharma industry, outsourced clinical manufacturers have recently seen a significant increase in business.
• 20/07/2012 ‘Xaluprine’, a liquid form of childhood leukaemia drug Mercaptopurine, will be distributed to hospital pharmacies across Europe after being granted an exclusive licence as an ‘orphan’ product by the European Commission.
• 21/05/2012 Nova Laboratories launched equine and canine compounding services at the BSAVA World Congress, strengthening its position as the leading supplier of veterinary reformulations.
• 19/10/2011 Please note the following arrangements in regards to the Christmas 2011 and New Year 2012 holidays.
• 08/08/2011 Nova’s management, are pleased that it’s Gassed Isolator technology is featured in the August edition of Cleanroom Technology magazine.
• 28/07/2011 An oral suspension of leukaemia medicine mercaptopurine has moved a key step closer to the European pharmaceutical market.
• 04/05/2011 When Leicester Royal Infirmary were looking for a company to supply materials for their ground breaking clinical trial into the treatment of bowel cancer, they turned to Nova...
• 01/05/2011 Manufacturer Nova Laboratories has pioneered a veterinary compounding and reformulation service within Cascade, due to demand from ‘early adopter’ vets.
• 20/04/2011 Instantly injectable, thermo-stable vaccines at tropical temperatures have attracted interest from around the world, writes John Seaton, of Nova Bio-Pharma Technologies Ltd.
• 08/04/2011 Pharma companies should focus on their core skills in their own industry - and let those with the knowledge and expertise gained in specialist areas support them and make a huge difference.
• 01/03/2011 Vets can offer a better range of medicines and improve cat compliance, thanks to Nova Laboratories’ pioneering compounding and reformulation service.
• 12/01/2011 I recently interviewed Nova Laboratories’ Commercial & Financial Director John Seaton. 2010 has been a year of significant growth/success for the specials and aseptic manufacturing specialist, especially since the company announced, in mid 2009, its acquisition of the assets of temperature-stable liquid vaccines developer Cambridge Biostability, and a storage facility, providing an extra 1,400 sq. m. of space. John talked about…
• 21/09/2010 Nova Laboratories was pleased to be asked to contribute to a recent BBC investigation into the rising cost of “Specials” within the NHS.
• 14/05/2010 Nova’s commercial team have recently returned from a successful trip to BIO 2010.
• 04/12/2009 Nova confirms that its Non-Sterile Compunding Unit, will once again be open to support its customers between Christmas and New Year.
• 22/09/2009 Nova Laboratories has today confirmed, that due to an increasing number of enquiries from North America, it has decided to exhibit at BIO International Convention 2010.
• 13/08/2009 Nova Laboratories Ltd has acquired the assets of Cambridge Biostability Ltd, including the intellectual property for two key technologies, the VitRIS and HydRIS platforms.
• 24/07/2009 Nova Laboratories has signed a 25 year lease on new premises, providing approximately 1400sq metres of additional space.
• 01/06/2009 Nova will once again be exhibiting at the 2009 Pharmacy Show.
• 15/05/2009 Nova is currently preparing its stand for the ICSE Madrid 2009 event, which is being held at Feria de Madrid, Spain on 13-15 October 2009.
• 29/04/2009 Nova Laboratories recently sent members of its commercial team to the ICSE exhibition in Tokyo.
• 27/11/2008 Nova has signed a new contract worth in excess of £10m.
• 27/10/2008 A pharmaceutical product is now commercially available as a pre-filled syringe.
• 14/10/2008 Nova, happy to meet customers new and old.
• 03/10/2008 Nova has been promoting its services to industrial customers.
• 12/09/2008 Nova successfully filled its first batch of live biologics.
• 23/07/2008 Nova today completed the purchase of an additional building.
• 18/07/2008 Nova has executed a lease on property adjoining its operations at Martin House.
• 06/05/2008 Nova listed as a Profit Track 100 company for 2008